A medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders.


Updates from The Motley Fool

Latest updates on NuVasive from Fool.com.  The Fool has written over 100 articles on NuVasive.
Why NuVasive Inc. Shares Jumped

NuVasive surprises Wall Street with an upbeat fourth-quarter and fiscal 2014 forecast. Should inv...



Stock Performance

View Interactive NUVA Charts
Sponsored by

Key Data Points

Primary metrics and data points about NuVasive.
Current Price: $71.54
Prev Close: $70.88
Open: $70.93
Bid: $70.00
Ask: $76.88
Day's Range: $70.72 - $71.78
52wk Range: $53.05 - $77.88
Volume: 459,462
Avg Vol 713,482
Market Cap: $4B
P/E (ttm): 72.33
EPS (ttm): $0.98
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about NuVasive.
CAPS Rating 5 out of 5
 
261 Outperform
16 Underperform
CAPS All Stars
 
69 Outperform
3 Underperform

How do you think NuVasive will perform against the market?



You pick for NuVasive is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Greg Lucier, CEO

96% Approve

Based on 32 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for NuVasive.

A medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT